Medtronic To Pay Over $1Billion To Settle Patent Litigation With Edwards Lifesciences

After years of protracted and often bitter litigation in the US and abroad, Edwards Lifesciences and Medtronic today announced a broad resolution to all their patent disputes over transcatheter heart valves.

Medtronic will pay more than a billion dollars over the course of the agreement, which lasts until April 2022.

Click here to read the full post on Forbes.

 

Leave a Reply

%d bloggers like this: